WBA Stock Up on Q4 Earnings & Revenues Beat, Unveils Strategic Action

Published on 15 Oct 2024 on Zacks

Walgreens reports better-than-expected earnings and revenues in the fourth quarter of fiscal 2024.

Read the rest of the article

Start tracking your investments with Statfolio

These factors are likely to have favored the stock’s growth. Risk Factors COR’s gross margin...

Zacks · via Yahoo Finance 22 Nov 2024

The availability of the FDA-approved drug via McKesson's cell and gene therapies business is...

Zacks · via Yahoo Finance 21 Nov 2024

The Zacks Consensus Estimate for the year’s adjusted earnings is pegged at $5.44 per share. Our T...

Zacks · via Yahoo Finance 19 Nov 2024

Patterson Companies, Inc.'s PDCO subsidiary, Patterson Dental Supply, Inc., recently announced an...

Zacks · via Yahoo Finance 19 Nov 2024

The stock is up 15.2% year-to-date. The consensus estimate for Halozyme Therapeutics' current yea...

Zacks · via Yahoo Finance 19 Nov 2024

Walgreens reports better-than-expected earnings and revenues in the fourth quarter of fiscal 2024.

Zacks 15 Oct 2024

Walgreens Boots Alliance (NASDAQ:WBA) announced plans to close approximately 1,200 underperformin...

Investing.com 15 Oct 2024

Walgreens Boots Alliance Outlines Three-Cost Saving Strategy As Q4 Earnings Beat Street Estimates...

Benzinga · via Yahoo Finance 15 Oct 2024

Robust revenue growth with a 10.9% increase in the recent quarter. Continued market dominance as ...

GuruFocus.com · via Yahoo Finance 25 Jul 2024

Cencora (COR) shares declined on Jun 27, following an unfavorable ruling from the Supreme Court...

Zacks · via Yahoo Finance 24 Jun 2024